Control of lens fiber cell denucleation by CDK1 and its regulators

被引:0
|
作者
Whitcomb, Elizabeth [1 ]
Chang, Min-Lee [1 ]
Gu, Yumei [1 ]
Yang, Wenxin [1 ]
Francisco, Sarah G. [1 ]
Pruitt, Steven [2 ]
Zhu, Liang [3 ]
Kantorow, Marc [4 ]
Taylor, Allen [1 ]
机构
[1] Tufts Univ, JM USDA Human Nutr Res Ctr Aging, Lab Nutr & Vis Res, Boston, MA 02111 USA
[2] Roswell Park Canc Inst, Buffalo, NY 14263 USA
[3] Albert Einstein Coll Med, New York, NY USA
[4] Florida Atlantic Univ, Boca Raton, FL 33431 USA
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
2302
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Long term effects of tryptophane deficiency on lens fiber cell differentiation and denucleation in pigmented rats
    Wegener, A
    DeWolf, A
    Vrensen, G
    Breipohl, W
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (04) : S517 - S517
  • [32] The Progress of Cell Cycle Cdk1 Inhibitors in Budding Yeast
    Liu Xue-Qin
    Ren Ping
    Zhang Ze
    Zeng Fan-Li
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2018, 45 (05) : 512 - 518
  • [33] CDK1 phosphorylation of TAZ in mitosis inhibits its oncogenic activity
    Zhang, Lin
    Chen, Xingcheng
    Stauffer, Seth
    Yang, Shuping
    Chen, Yuanhong
    Dong, Jixin
    ONCOTARGET, 2015, 6 (31) : 31399 - 31412
  • [34] Phosphorylation of NuSAP by Cdk1 regulates its interaction with microtubules in mitosis
    Chou, Han-Yi
    Wang, Ting-Huang
    Lee, Sheng-Chung
    Hsu, Pang-Hung
    Tsai, Ming-Daw
    Chang, Chih-Ning
    Jeng, Yung-Ming
    CELL CYCLE, 2011, 10 (23) : 4083 - 4089
  • [35] CDK1 AND CDK2 ACTIVITY IS A STRONG PREDICTOR OF RENAL CELL CANCER RECURRENCE
    Hongo, F.
    Takaha, N.
    Kimura, Y.
    Nakamura, T.
    Mikami, K.
    Nakayama, S.
    Matsushima, T.
    Ishihara, H.
    Sakai, T.
    Miki, T.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 138 - 139
  • [36] Use of CDK1 and CDK2 activity to predict renal cell cancer recurrence
    Hongo, F.
    Takaha, N.
    Kimura, Y.
    Nakamura, T.
    Mikami, K.
    Nakayama, S.
    Matsushima, T.
    Ishihara, H.
    Sakai, T.
    Miki, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [37] CDK1 and CDK2 activity is a strong predictor of renal cell cancer recurrence
    Hongo, Fumiya
    Takaha, Natsuki
    Kimura, Yasunori
    Nakamura, Terukazu
    Mikami, Kazuya
    Nakayama, Satoshi
    Matsushima, Tomoko
    Ishihara, Hideki
    Sakai, Toshiyuki
    Miki, Tsuneharu
    CANCER RESEARCH, 2011, 71
  • [38] CDK1 and CDK2 activity is a strong predictor of renal cell carcinoma recurrence
    Hongo, Fumiya
    Takaha, Natsuki
    Oishi, Masakatsu
    Ueda, Takashi
    Nakamura, Terukazu
    Naitoh, Yasuyuki
    Naya, Yoshio
    Kamoi, Kazumi
    Okihara, Koji
    Matsushima, Tomoko
    Nakayama, Satoshi
    Ishihara, Hideki
    Sakai, Toshiyuki
    Miki, Tsuneharu
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (08) : 1240 - 1246
  • [39] Use of CDK1 and CDK2 activity to predict renal cell cancer recurrence
    Hongo, F.
    Takaha, N.
    Kimura, Y.
    Nakamura, T.
    Mikami, K.
    Nakayama, S.
    Shibayama, M.
    Ishihara, H.
    Sakai, T.
    Miki, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [40] CDK1 AND CDK2 ACTIVITY IS A STRONG PREDICTOR OF RENAL CELL CANCER RECURRENCE
    Hongo, Fumiya
    Takaha, Natsuki
    Kimura, Yasunori
    Nakamura, Terukazu
    Mikami, Kazuya
    Nakayama, Satoshi
    Matsushima, Tomoko
    Ishihara, Hideaki
    Sakai, Toshiyuki
    Miki, Tsuneharu
    JOURNAL OF UROLOGY, 2011, 185 (04): : E390 - E390